US stocks closed lower on Tuesday as market participants digested some key corporate earnings and news of a pause in Johnson & Johnson's Covid-19 vaccine study.
European shares were knocked lower by continued worries over the rising number of novel coronavirus cases across the Continent and doubts over the chances for further fiscal stimulus in the US before the next presidential elections on 3 November.
London stocks closed weaker on Tuesday, dipping below 6,000 points at the end of the day, as investors mulled disappointing UK jobs data and the pausing of a Johnson & Johnson Covid-19 vaccine trial.
Stocks were pummeled on Tuesday as concerns mounted that the rising rate of Covid-19 infections might force the government into tightening lockdown measures further, on top of a day fraught with nervousness around the ongoing Brexit talks with Brussels.
Analysts at Berenberg hiked their target price on power supply manufacturer XP Power from 4,980. 0p to 5,230. 0p on Tuesday, stating its upgrade cycle was continuing.
The focus on Wednesday will continue to be on incoming earnings reports Stateside, including several of the top-tier lenders, against a backdrop of speeches from central bank officials on both sides of the Pond.
Morocco-focussed upstream gas company Sound Energy reported a 24-month extension to the initial period of the Sidi Moktar Permits, onshore Morocco, on Tuesday.
Naked Wines revealed on Tuesday that chief executive officer Nicholas Devlin had acquired 10,280 ordinary shares in the AIM-listed online wine retailer.
Keras Resources updated the market on progress at the Diamond Creek high-grade direct shipping ore organic phosphate mine in Utah and the Nayéga manganese mine in Togo on Tuesday, reporting that the 2020 mining campaign was now complete at Diamond Creek.
The global economy will endure a slightly less horrid contraction over the course of the year than previously anticipated, the International Monetary Fund said.
London’s FTSE 250 was down 1. 4% at 17,912. 80 in afternoon trade on Tuesday.
US stocks were lower at the bell on Tuesday as market participants digested some key corporate earnings and news of a pause in Johnson & Johnson's Covid-19 vaccine study.
Source BioScience, a specialist in Covid-19 diagnostics, is to return to the London stock market in a potential £130m initial public offering.
London’s FTSE 100 was down 0. 5% at 5,974. 61 in afternoon trade on Tuesday.
Analysts at Citi bumped up their profit estimates and target price for shares of Pets at Home Group, highlighting both its "strong" market share and structural market growth which might pave the way for the generation of excess capital.
BlueRock Diamonds updated the market on third quarter production at the Kareevlei mine in South Africa on Tuesday, reporting record tonnage, carats and grades for the period.
Round Hill Music Royalty Fund has announced its intention to float on the London Stock Exchange's specialist fund segment.
Banking giant Citigroup posted its largest quarterly profit of the Covid-19 pandemic on Tuesday, as trading bonds afforded the firm another windfall.
Analytics company Actual Experience announced on Tuesday that, following the recent development of its new ‘Human Experience Management’ (HXM) offerings for its partners, it has signed a three-year extension of its framework agreement with Accenture’s procurement arm Proquire.
A rebound in global financial markets helped JPMorgan Chase post a 4% jump in third-quarter income, the Wall Street bank confirmed on Tuesday.